Beyond, Inc. SEC Filings

Bed Bath & Beyond, Inc. (BBBY) reported that one of its executives, serving as Executive Vice President, Chief Digital, Product, and Technology Officer, filed an initial ownership report on Form 3 as of 11/14/2025. The filing states that this officer currently does not beneficially own any Bed Bath & Beyond securities, and both the non-derivative and derivative ownership tables show no reported holdings.

Bed Bath & Beyond (BBBY) Chief Accounting Officer, who files individually, reported equity award activity and a warrant distribution. On 11/15/2025, the officer acquired 1,186 shares of common stock at an exercise price of $0.0001 through the vesting and settlement of restricted stock units, and disposed of 289 shares at $6.03, typically reflecting shares withheld or sold to cover taxes. Following these transactions, the officer directly holds 3,077 shares of common stock.

In the derivative table, the officer shows 26,906 restricted stock units beneficially owned after the reported RSU conversion, each representing one share of common stock, vesting in two equal installments on November 15, 2025 and November 15, 2026. The officer also acquired 218 common stock warrants with a $15.50 exercise price from an October 7, 2025 pro-rata distribution to all common shareholders, which become exercisable once an S-3 registration statement for the warrant shares is declared effective and remain exercisable through October 7, 2026.

Bed Bath & Beyond (BBBY) Chief Accounting Officer, who files individually, reported equity award activity and a warrant distribution. On 11/15/2025, the officer acquired 1,186 shares of common stock at an exercise price of $0.0001 through the vesting and settlement of restricted stock units, and disposed of 289 shares at $6.03, typically reflecting shares withheld or sold to cover taxes. Following these transactions, the officer directly holds 3,077 shares of common stock.

In the derivative table, the officer shows 26,906 restricted stock units beneficially owned after the reported RSU conversion, each representing one share of common stock, vesting in two equal installments on November 15, 2025 and November 15, 2026. The officer also acquired 218 common stock warrants with a $15.50 exercise price from an October 7, 2025 pro-rata distribution to all common shareholders, which become exercisable once an S-3 registration statement for the warrant shares is declared effective and remain exercisable through October 7, 2026.

Bed Bath & Beyond Inc.'s Chief Operating Officer reported equity transactions reflecting routine compensation activity. On 11/15/2025, 1,186 shares of common stock were acquired upon the vesting and settlement of restricted stock units at an exercise price of $0.0001 per share, and 343 shares were disposed of at $6.03 per share, typically consistent with tax withholding. Following these transactions, the reporting person directly owned 8,793 common shares and indirectly held 66 shares through a 401(k) plan balance as of 11/17/2025.

In the derivative table, 1,186 restricted stock units converted into common stock, leaving 43,143 derivative securities reported as beneficially owned. The filing also lists 794 common stock warrants with an exercise price of $15.50 per share, originally issued on 10/07/2025 as a pro-rata distribution. These warrants will become exercisable once a Form S-3 registering the underlying shares is declared effective by the SEC and may be exercised through 10/07/2026.

Bed Bath & Beyond Inc.'s Chief Operating Officer reported equity transactions reflecting routine compensation activity. On 11/15/2025, 1,186 shares of common stock were acquired upon the vesting and settlement of restricted stock units at an exercise price of $0.0001 per share, and 343 shares were disposed of at $6.03 per share, typically consistent with tax withholding. Following these transactions, the reporting person directly owned 8,793 common shares and indirectly held 66 shares through a 401(k) plan balance as of 11/17/2025.

In the derivative table, 1,186 restricted stock units converted into common stock, leaving 43,143 derivative securities reported as beneficially owned. The filing also lists 794 common stock warrants with an exercise price of $15.50 per share, originally issued on 10/07/2025 as a pro-rata distribution. These warrants will become exercisable once a Form S-3 registering the underlying shares is declared effective by the SEC and may be exercised through 10/07/2026.

Bed Bath & Beyond Inc. (BBBY): A series of the Amplify ETF Trust filed a Schedule 13G reporting beneficial ownership of 4,496,275 shares of BBBY common stock, representing 6.53% of the class as of 09/30/2025.

The filer reports sole voting power over 4,496,275 shares and sole dispositive power over 4,496,275 shares, with no shared voting or dispositive power. The filing identifies the filer as an investment company registered under section 8 of the Investment Company Act of 1940.

The filing notes the fund’s clients have the right to receive or direct the receipt of dividends or sale proceeds from the reported securities, and that no one other person’s interest exceeds 5%.

Bed Bath & Beyond Inc. (BBBY): A series of the Amplify ETF Trust filed a Schedule 13G reporting beneficial ownership of 4,496,275 shares of BBBY common stock, representing 6.53% of the class as of 09/30/2025.

The filer reports sole voting power over 4,496,275 shares and sole dispositive power over 4,496,275 shares, with no shared voting or dispositive power. The filing identifies the filer as an investment company registered under section 8 of the Investment Company Act of 1940.

The filing notes the fund’s clients have the right to receive or direct the receipt of dividends or sale proceeds from the reported securities, and that no one other person’s interest exceeds 5%.

Bed Bath & Beyond, Inc. announced the adoption of its 2025 Employment Inducement Equity Incentive Plan. The plan reserves a maximum of 1,500,000 shares of common stock for equity-based awards.

Adopted without stockholder approval under NYSE Rule 303A.08, the plan permits non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. Grants may be made only as “employment inducement” awards and must be approved by a majority of Independent Directors or the Compensation Committee composed solely of Independent Directors.

Bed Bath & Beyond, Inc. announced the adoption of its 2025 Employment Inducement Equity Incentive Plan. The plan reserves a maximum of 1,500,000 shares of common stock for equity-based awards.

Adopted without stockholder approval under NYSE Rule 303A.08, the plan permits non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards. Grants may be made only as “employment inducement” awards and must be approved by a majority of Independent Directors or the Compensation Committee composed solely of Independent Directors.

The Vanguard Group filed Amendment No. 8 to Schedule 13G reporting beneficial ownership of 3,732,108 shares of Bed Bath & Beyond Inc. common stock, representing 6.5% of the class as of September 30, 2025.

Vanguard reports 0 shares with sole voting power and 342,440 with shared voting power. It has 3,368,994 shares with sole dispositive power and 363,114 with shared dispositive power. The filing identifies Vanguard as an investment adviser and states the securities were acquired and are held in the ordinary course, not to change or influence control.

Vanguard notes its clients, including registered investment companies and other managed accounts, may receive dividends or sale proceeds related to these securities, and no other single person’s interest exceeds five percent.

The Vanguard Group filed Amendment No. 8 to Schedule 13G reporting beneficial ownership of 3,732,108 shares of Bed Bath & Beyond Inc. common stock, representing 6.5% of the class as of September 30, 2025.

Vanguard reports 0 shares with sole voting power and 342,440 with shared voting power. It has 3,368,994 shares with sole dispositive power and 363,114 with shared dispositive power. The filing identifies Vanguard as an investment adviser and states the securities were acquired and are held in the ordinary course, not to change or influence control.

Vanguard notes its clients, including registered investment companies and other managed accounts, may receive dividends or sale proceeds related to these securities, and no other single person’s interest exceeds five percent.

Bed Bath & Beyond, Inc. (BBBY) reported Q3 results for the period ended September 30, 2025. Net revenue was $257.2 million, down 17% year over year, as orders fell and average order value rose slightly. Gross margin improved to 25.3% from 21.2%, keeping gross profit roughly flat at $65.2 million. Operating loss narrowed to $(12.5) million from $(45.2) million, and net loss improved to $(4.5) million (basic and diluted EPS $(0.07)) from $(61.0) million.

Expenses declined across sales and marketing, technology, and G&A, reflecting tighter spending. Cash and cash equivalents were $167.4 million as of September 30, 2025. The company raised $101.7 million net by selling 12,432,021 shares under its at‑the‑market program, repurchased $4.9 million in Q3 and $6.2 million year to date, and had $63.7 million remaining on its repurchase authorization.

Strategic brand moves included acquiring buybuy BABY IP for $7.1 million, purchasing the Kirkland’s brand for $12.9 million, and recognizing a $5.0 million gain from selling Bed Bath & Beyond trademarks in Canada/UK. Subsequent event: a warrant dividend of one warrant per ten shares, exercisable at $15.50 and expiring on October 7, 2026, subject to early‑expiration conditions.

Bed Bath & Beyond, Inc. (BBBY) reported Q3 results for the period ended September 30, 2025. Net revenue was $257.2 million, down 17% year over year, as orders fell and average order value rose slightly. Gross margin improved to 25.3% from 21.2%, keeping gross profit roughly flat at $65.2 million. Operating loss narrowed to $(12.5) million from $(45.2) million, and net loss improved to $(4.5) million (basic and diluted EPS $(0.07)) from $(61.0) million.

Expenses declined across sales and marketing, technology, and G&A, reflecting tighter spending. Cash and cash equivalents were $167.4 million as of September 30, 2025. The company raised $101.7 million net by selling 12,432,021 shares under its at‑the‑market program, repurchased $4.9 million in Q3 and $6.2 million year to date, and had $63.7 million remaining on its repurchase authorization.

Strategic brand moves included acquiring buybuy BABY IP for $7.1 million, purchasing the Kirkland’s brand for $12.9 million, and recognizing a $5.0 million gain from selling Bed Bath & Beyond trademarks in Canada/UK. Subsequent event: a warrant dividend of one warrant per ten shares, exercisable at $15.50 and expiring on October 7, 2026, subject to early‑expiration conditions.

Bed Bath & Beyond, Inc. reported that it issued a press release with financial results for the three and nine months ended September 30, 2025. The company furnished the release as Exhibit 99.1 and posted an updated investor presentation in the Events & Presentation section of its investor relations site.

The information provided under Item 2.02 and in Exhibit 99.1 is furnished and not deemed filed under the Exchange Act.

Bed Bath & Beyond, Inc. reported that it issued a press release with financial results for the three and nine months ended September 30, 2025. The company furnished the release as Exhibit 99.1 and posted an updated investor presentation in the Events & Presentation section of its investor relations site.

The information provided under Item 2.02 and in Exhibit 99.1 is furnished and not deemed filed under the Exchange Act.

BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 4,123,240 shares of Bed Bath & Beyond, Inc. common stock, representing 7.2% of the class as of 09/30/2025. BlackRock reported sole voting power over 4,025,167 shares and sole dispositive power over 4,123,240 shares, with no shared voting or dispositive power.

BlackRock certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing is signed by a Managing Director and includes a Power of Attorney exhibit.

BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 4,123,240 shares of Bed Bath & Beyond, Inc. common stock, representing 7.2% of the class as of 09/30/2025. BlackRock reported sole voting power over 4,025,167 shares and sole dispositive power over 4,123,240 shares, with no shared voting or dispositive power.

BlackRock certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing is signed by a Managing Director and includes a Power of Attorney exhibit.

Bed Bath & Beyond, Inc. updated its dealings with The Brand House Collective, Inc. on September 15, 2025. The company amended its existing term loan credit agreement to add new delayed-draw term loan commitments with an aggregate original principal amount of $20 million, which the company can convert into equity of The Brand House Collective, up to 75% of its outstanding common stock, under agreed conditions.

The company also amended its asset purchase agreement for the Kirkland’s brand, increasing the total purchase price from $5.233 million to $10 million for trademarks, domain names, and related brand assets, paid at closing on September 15, 2025. At the same time, Bed Bath & Beyond amended the existing trademark license so The Brand House Collective can continue using the Kirkland’s brand for its current stores, websites, and products, including an exclusive license for existing brick-and-mortar stores that lasts until the earlier of September 15, 2027 or the rebranding or closure of all such stores.